Resveratrol-induced apoptotic cell death in glioma

白藜芦醇诱导神经胶质瘤细胞凋亡

基本信息

  • 批准号:
    7477902
  • 负责人:
  • 金额:
    $ 17.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-01 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Glioma is a malignant brain tumor in adults, difficult to treat and resistant to conventional radiotherapy and chemotherapy. Several major signaling cascades have been implicated in the development of gliomas, which include over-expression and activation of growth factors and their receptors (i.e. EGFR), over-expression and activation of intracellular signaling proteins (i.e. PI3-K/Akt) and deregulation of cell proliferation and the cell cycle. Resveratrol (trans-3,4',5-trihydroxystilbene) is a polyphenolic compound highly enriched in grapes, peanuts, red wine and a variety of plant and food sources. Resveratrol has been reported to have anti-inflammatory and antioxidant properties and acts as a cancer chemopreventive agent, inhibiting different steps of the carcinogenesis process, such as tumor initiation, promotion and progression. However, the signaling mechanisms mediated by resveratrol are not well defined in vivo. Our published in vitro studies show that resveratrol suppresses cell proliferation and induces apoptotic cell death in human U251 glioma cells in a dose- and time-dependent manner. Activation of caspases and suppression of phosphatidylinositol 3-kinase (PI3-K)/protein kinase B (Akt)-mediated signaling pathways are involved in this process. In the current study, we investigate the effect of resveratrol on the suppression of tumor growth and its underlying molecular mechanism in vivo using a U251 intracerebral glioma model in nude mice. We hypothesize that resveratrol suppresses the development of glioma in vivo through the down-regulation of expression and/or suppression of the activation of EGFR- and PI3-K/Akt-mediated signaling pathways. Specifically, the effect of resveratrol on the tumor growth will be determined and the regulation of EGFR/PI3-K/Akt-mediated signaling pathways by resveratrol will be examined. Natural products, such as resveratrol, usually have little or no toxic effects, are low cost and can be consumed orally. Development of potential preventive or adjunctive therapies using such products will be of great benefit for the treatment of glioma, as well as other human diseases. Glioma is a malignant brain tumor in adults, which is difficult to treat and resistant to conventional radiotherapy and chemotherapy. Resveratrol is a polyphenolic compound highly enriched in grapes, peanuts, red wine and a variety of plant and food sources. Resveratrol has anti-inflammatory and antioxidant properties and acts as a cancer chemopreventive agent. Our in vitro studies show that resveratrol suppresses cell proliferation and induces apoptotic cell death in glioma cells. Therefore, we seek to test the effect of resveratrol in vivo using a well-established animal model of glioma. By elucidating the molecular mechanisms underlying the therapeutic effects of resveratrol, this study would facilitate the development of therapeutic agents using natural products and greatly improve the treatment of brain tumors.
描述(申请人提供):胶质瘤是一种成人恶性脑肿瘤,治疗难度大,对常规放疗和化疗有抵抗力。神经胶质瘤的发展涉及几种主要的信号级联反应,其中包括生长因子及其受体(即 EGFR)的过度表达和激活、细胞内信号蛋白(即 PI3-K/Akt)的过度表达和激活以及失调细胞增殖和细胞周期。白藜芦醇(反式 3,4',5-三羟基二苯乙烯)是一种多酚化合物,富含于葡萄、花生、红酒以及多种植物和食物来源中。据报道,白藜芦醇具有抗炎和抗氧化特性,可作为癌症化学预防剂,抑制癌变过程的不同步骤,例如肿瘤的发生、促进和进展。然而,白藜芦醇介导的信号传导机制在体内尚未明确。我们发表的体外研究表明,白藜芦醇以剂量和时间依赖性方式抑制人 U251 神经胶质瘤细胞的细胞增殖并诱导细胞凋亡。该过程涉及半胱天冬酶的激活和磷脂酰肌醇 3-激酶 (PI3-K)/蛋白激酶 B (Akt) 介导的信号通路的抑制。在本研究中,我们利用U251裸鼠脑内胶质瘤模型研究了白藜芦醇抑制肿瘤生长的作用及其体内潜在的分子机制。我们假设白藜芦醇通过下调 EGFR 和 PI3-K/Akt 介导的信号通路的表达和/或抑制激活来抑制体内神经胶质瘤的发展。具体而言,将确定白藜芦醇对肿瘤生长的影响,并检查白藜芦醇对 EGFR/PI3-K/Akt 介导的信号通路的调节。天然产物,如白藜芦醇,通常几乎没有或没有毒性作用,成本低廉,可以口服。使用此类产品开发潜在的预防或辅助疗法将对神经胶质瘤以及其他人类疾病的治疗大有裨益。胶质瘤是一种成人恶性脑肿瘤,治疗难度大,对常规放疗和化疗耐药。白藜芦醇是一种多酚化合物,富含于葡萄、花生、红酒以及多种植物和食物来源中。白藜芦醇具有抗炎和抗氧化特性,可作为癌症化学预防剂。我们的体外研究表明,白藜芦醇可抑制神经胶质瘤细胞的细胞增殖并诱导细胞凋亡。因此,我们试图使用完善的神经胶质瘤动物模型来测试白藜芦醇的体内作用。通过阐明白藜芦醇治疗作用的分子机制,这项研究将有助于利用天然产物开发治疗药物,并极大地改善脑肿瘤的治疗。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells.
白藜芦醇下调人 U251 神经胶质瘤细胞中的 PI3K/Akt/mTOR 信号通路。
Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells.
白藜芦醇和萝卜硫素联合治疗可诱导人 U251 神经胶质瘤细胞凋亡。
  • DOI:
  • 发表时间:
    2010-01
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Jiang, Hao;Shang, Xia;Wu, Hongtao;Huang, Grace;Wang, Yiyang;Al;Gautam, Subhash C;Chopp, Michael
  • 通讯作者:
    Chopp, Michael
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAO JIANG其他文献

HAO JIANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAO JIANG', 18)}}的其他基金

SBIR TOPIC 417: QUANTITATIVE IMAGING SOFTWARE TOOLS FOR CANCER DIAGNOSIS AND TREATMENT PLANNING
SBIR 主题 417:用于癌症诊断和治疗计划的定量成像软件工具
  • 批准号:
    10924835
  • 财政年份:
    2023
  • 资助金额:
    $ 17.76万
  • 项目类别:
Development of Multilayer Strip Ion Chamber Device for the Measurement of Proton FLASH-Radiotherapy
用于测量质子闪光放射治疗的多层条形电离室装置的开发
  • 批准号:
    10714482
  • 财政年份:
    2022
  • 资助金额:
    $ 17.76万
  • 项目类别:
SBIR TOPIC 417 Multiple Brain Metastases Stereotactic Radiosurgery Management Platform - Detection, Planning and Follow-up
SBIR TOPIC 417 多发性脑转移瘤立体定向放射外科管理平台 - 检测、规划和随访
  • 批准号:
    10496726
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
SBIR TOPIC 417 Multiple Brain Metastases Stereotactic Radiosurgery Management Platform - Detection, Planning and Follow-up
SBIR TOPIC 417 多发性脑转移瘤立体定向放射外科管理平台 - 检测、规划和随访
  • 批准号:
    10579810
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
Resveratrol-induced apoptotic cell death in glioma
白藜芦醇诱导神经胶质瘤细胞凋亡
  • 批准号:
    7313929
  • 财政年份:
    2007
  • 资助金额:
    $ 17.76万
  • 项目类别:

相似国自然基金

基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
  • 批准号:
    82372499
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
  • 批准号:
    82373465
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
  • 批准号:
    82300208
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Nutrient-dependent regulation of neural stem cell proliferation and neural circuit formation
神经干细胞增殖和神经回路形成的营养依赖性调节
  • 批准号:
    10206910
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
Outer Membrane Proteins of Pathogenic Oral Treponemes Inhibit Actin Rearrangement and Antimicrobial Functions of Neutrophils
致病性口腔密螺旋体外膜蛋白抑制中性粒细胞肌动蛋白重排和抗菌功能
  • 批准号:
    10491690
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
Investigating additive impact of heat stress on zearalenone-induced ovotoxicity
研究热应激对玉米赤霉烯酮诱导的卵毒性的附加影响
  • 批准号:
    10315882
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
Investigating additive impact of heat stress on zearalenone-induced ovotoxicity
研究热应激对玉米赤霉烯酮诱导的卵毒性的附加影响
  • 批准号:
    10457868
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
Nutrient-dependent regulation of neural stem cell proliferation and neural circuit formation
神经干细胞增殖和神经回路形成的营养依赖性调节
  • 批准号:
    10442438
  • 财政年份:
    2021
  • 资助金额:
    $ 17.76万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了